A citation-based method for searching scientific literature

Delia Colombo, Micol Frassi, Giusy Pagano Mariano, Enrico Fusaro, Claudia Lomater, Patrizia Del Medico, Florenzo Iannone, Rosario Foti, Massimiliano Limonta, Antonio Marchesoni, Bernd Raffeiner, Ombretta Viapiana, Walter Grassi, Rosa Daniela Grembiale, Giuliana Guggino, Antonino Mazzone, Enrico Tirri, Roberto Perricone, Pier Carlo Sarzi Puttini, Salvatore De Vita, Fabrizio Conti, Alessandra Ori, Lucia Simoni, Martina Fiocchi, Roberto Orsenigo, Emanuela Zagni. BMC Rheumatol 2022
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Policies for Use of Real-World Data in Health Technology Assessment (HTA): A Comparative Study of Six HTA Agencies.
Amr Makady, Renske Ten Ham, Anthonius de Boer, Hans Hillege, Olaf Klungel, Wim Goettsch. Value Health 2017
96
100

Secukinumab for Long-Term Treatment of Psoriatic Arthritis: A Two-Year Followup From a Phase III, Randomized, Double-Blind Placebo-Controlled Study.
Arthur Kavanaugh, Philip J Mease, Andreas M Reimold, Hasan Tahir, Jürgen Rech, Stephen Hall, Piet Geusens, Zailong Wang, Luminita Pricop, Shephard Mpofu. Arthritis Care Res (Hoboken) 2017
57
100

Etanercept and Methotrexate as Monotherapy or in Combination for Psoriatic Arthritis: Primary Results From a Randomized, Controlled Phase III Trial.
Philip J Mease, Dafna D Gladman, David H Collier, Christopher T Ritchlin, Philip S Helliwell, Lyrica Liu, Gregory Kricorian, James B Chung. Arthritis Rheumatol 2019
96
100

Ixekizumab Effectiveness and Safety in the Treatment of Moderate-to-Severe Plaque Psoriasis: A Multicenter, Retrospective Observational Study.
Andrea Chiricozzi, Martina Burlando, Giacomo Caldarola, Andrea Conti, Giovanni Damiani, Clara De Simone, Valentina Dini, Piergiorgio Malagoli, Francesca Peccerillo, Concetta Potenza,[...]. Am J Clin Dermatol 2020
21
100

Cost and Cost Effectiveness of Treatments for Psoriatic Arthritis: A Systematic Literature Review.
Lucia Sara D'Angiolella, Paolo Angelo Cortesi, Alessandra Lafranconi, Mariangela Micale, Sveva Mangano, Giancarlo Cesana, Lorenzo Giovanni Mantovani. Pharmacoeconomics 2018
22
100

Disease activity in psoriatic arthritis: comparison of the discriminative capacity and construct validity of six composite indices in a real world.
Fausto Salaffi, Alessandro Ciapetti, Marina Carotti, Stefania Gasparini, Marwin Gutierrez. Biomed Res Int 2014
56
100

The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials.
D T Felson, J J Anderson, M Boers, C Bombardier, M Chernoff, B Fried, D Furst, C Goldsmith, S Kieszak, R Lightfoot. Arthritis Rheum 1993
100

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis.
Laura C Coates, Arthur Kavanaugh, Philip J Mease, Enrique R Soriano, Maria Laura Acosta-Felquer, April W Armstrong, Wilson Bautista-Molano, Wolf-Henning Boehncke, Willemina Campbell, Alberto Cauli,[...]. Arthritis Rheumatol 2016
539
100

The Cost of Psoriasis and Psoriatic Arthritis in 5 European Countries: A Systematic Review.
R Burgos-Pol, J M Martínez-Sesmero, J M Ventura-Cerdá, I Elías, M T Caloto, M Á Casado. Actas Dermosifiliogr 2016
35
100

European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update.
L Gossec, J S Smolen, S Ramiro, M de Wit, M Cutolo, M Dougados, P Emery, R Landewé, S Oliver, D Aletaha,[...]. Ann Rheum Dis 2016
589
100

American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis.
D T Felson, J J Anderson, M Boers, C Bombardier, D Furst, C Goldsmith, L M Katz, R Lightfoot, H Paulus, V Strand. Arthritis Rheum 1995
100

Cost effectiveness of biologic therapies for plaque psoriasis.
Christine S Ahn, Cheryl J Gustafson, Laura F Sandoval, Scott A Davis, Steven R Feldman. Am J Clin Dermatol 2013
42
100

Mortality studies in psoriatic arthritis: results from a single outpatient clinic. I. Causes and risk of death.
K Wong, D D Gladman, J Husted, J A Long, V T Farewell. Arthritis Rheum 1997
278
100

Biologics in the treatment of psoriasis: clinical and economic overview.
Yves Poulin, Richard G Langley, Henrique D Teixeira, Marie-Josée Martel, Sun Cheung. J Cutan Med Surg 2009
19
100

Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT).
P J Mease, P Ory, J T Sharp, C T Ritchlin, F Van den Bosch, F Wellborne, C Birbara, G T D Thomson, R J Perdok, J Medich,[...]. Ann Rheum Dis 2009
194
100

Improved survival in psoriatic arthritis with calendar time.
Yaser Ali, Brian D M Tom, Catherine T Schentag, Vernon T Farewell, Dafna D Gladman. Arthritis Rheum 2007
81
100


Validation of rheumatoid arthritis improvement criteria that include simplified joint counts.
A M van Gestel, C J Haagsma, P L van Riel. Arthritis Rheum 1998
580
100


The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European dermatology clinics.
E Christophers, J N W N Barker, C E M Griffiths, E Daudén, G Milligan, C Molta, R Sato, R Boggs. J Eur Acad Dermatol Venereol 2010
101
100

The Development of Psoriatic Arthritis in Patients With Psoriasis Is Preceded by a Period of Nonspecific Musculoskeletal Symptoms: A Prospective Cohort Study.
Lihi Eder, Ari Polachek, Cheryl F Rosen, Vinod Chandran, Richard Cook, Dafna D Gladman. Arthritis Rheumatol 2017
62
100

Epidemiology of Psoriasis and Psoriatic Arthritis in Italy-a Systematic Review.
Francesca Prignano, Veronica Rogai, Elisabetta Cavallucci, Alessandro Bitossi, Volker Hammen, Fabrizio Cantini. Curr Rheumatol Rep 2018
18
100

Secukinumab in the treatment of psoriatic arthritis: efficacy and safety results through 3 years from the year 1 extension of the randomised phase III FUTURE 1 trial.
Philip J Mease, Arthur Kavanaugh, Andreas Reimold, Hasan Tahir, Jürgen Rech, Stephen Hall, Piet Geusens, Pascale Pellet, Evie Maria Delicha, Shephard Mpofu,[...]. RMD Open 2018
41
100

Secukinumab provides sustained PASDAS-defined remission in psoriatic arthritis and improves health-related quality of life in patients achieving remission: 2-year results from the phase III FUTURE 2 study.
L C Coates, D D Gladman, P Nash, O FitzGerald, A Kavanaugh, T K Kvien, L Gossec, V Strand, L Rasouliyan, L Pricop,[...]. Arthritis Res Ther 2018
21
100

Cost-Effectiveness of Targeted Pharmacotherapy for Moderate to Severe Plaque Psoriasis.
Nathaniel Hendrix, Daniel A Ollendorf, Richard H Chapman, Anne Loos, Shanshan Liu, Varun Kumar, Jeffrey A Linder, Steven D Pearson, David L Veenstra. J Manag Care Spec Pharm 2018
15
100

Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis.
Jasvinder A Singh, Gordon Guyatt, Alexis Ogdie, Dafna D Gladman, Chad Deal, Atul Deodhar, Maureen Dubreuil, Jonathan Dunham, M Elaine Husni, Sarah Kenny,[...]. Arthritis Care Res (Hoboken) 2019
133
100

Good practices for real-world data studies of treatment and/or comparative effectiveness: Recommendations from the joint ISPOR-ISPE Special Task Force on real-world evidence in health care decision making.
Marc L Berger, Harold Sox, Richard J Willke, Diana L Brixner, Hans-Georg Eichler, Wim Goettsch, David Madigan, Amr Makady, Sebastian Schneeweiss, Rosanna Tarricone,[...]. Pharmacoepidemiol Drug Saf 2017
168
100

Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics.
Alice Gottlieb, Neil J Korman, Kenneth B Gordon, Steven R Feldman, Mark Lebwohl, John Y M Koo, Abby S Van Voorhees, Craig A Elmets, Craig L Leonardi, Karl R Beutner,[...]. J Am Acad Dermatol 2008
315
100

Cost-effectiveness of systemic treatments for moderate-to-severe psoriasis in the German health care setting.
Denise Küster, Alexander Nast, Sascha Gerdes, Tobias Weberschock, Gottfried Wozel, Mandy Gutknecht, Jochen Schmitt. Arch Dermatol Res 2016
10
100

Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis.
Philip J Mease, Iain B McInnes, Bruce Kirkham, Arthur Kavanaugh, Proton Rahman, Désirée van der Heijde, Robert Landewé, Peter Nash, Luminita Pricop, Jiacheng Yuan,[...]. N Engl J Med 2015
501
100

Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial.
Iain B McInnes, Philip J Mease, Bruce Kirkham, Arthur Kavanaugh, Christopher T Ritchlin, Proton Rahman, Désirée van der Heijde, Robert Landewé, Philip G Conaghan, Alice B Gottlieb,[...]. Lancet 2015
536
100

Early and sustained efficacy with apremilast monotherapy in biological-naïve patients with psoriatic arthritis: a phase IIIB, randomised controlled trial (ACTIVE).
Peter Nash, Kamal Ohson, Jessica Walsh, Nikolay Delev, Dianne Nguyen, Lichen Teng, Juan J Gómez-Reino, Jacob A Aelion. Ann Rheum Dis 2018
47
100

Prevalence and incidence of psoriatic arthritis: A systematic review and meta-analysis.
Lorenza Scotti, Matteo Franchi, Antonio Marchesoni, Giovanni Corrao. Semin Arthritis Rheum 2018
68
100

Analysis of drug utilization and health care resource consumption in patients with psoriasis and psoriatic arthritis before and after treatment with biological therapies.
Luca Degli Esposti, Valentina Perrone, Diego Sangiorgi, Stefano Buda, Margherita Andretta, Maurizio Rossini, Giampiero Girolomoni. Biologics 2018
11
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.